Tirzepatide 20mg — Vial Spec, Reconstitution Math & COA
A 20mg vial of tirzepatide provides high-yield research material suited for multi-plate in vitro screening and longitudinal preclinical bioassays. This technical guide outlines chemical specifications, precise reconstitution calculations across various diluent volumes, analytical verification via lot-matched COAs, and handling protocols for specialized laboratory environments.
Quick answer
A 20mg vial of tirzepatide provides high-yield research material suited for multi-plate in vitro screening and longitudinal preclinical bioassays. This technical guide outlines chemical specifications, precise reconstitution calculations across various diluent volumes, analytical verification via lot-matched COAs, and handling protocols for specialized laboratory environments.
Key takeaways
- A 20mg vial of [tirzepatide](/research-peptides/tirzepatide) contains a highly purified, lyophilized cake composed of twenty milligrams of active peptide mass paired with a stabilizing excipient matrix (such as mannitol or trehalose) to maintain structural integrity during vacuum-drying and storage.
- At PX1 Research, product offerings are constantly calibrated to match dynamic academic and industrial research demands.
- [Tirzepatide](/research-peptides/tirzepatide) represents a distinct structural class of incretin mimetics known as dual GIP/GLP-1 receptor agonists, or 'twincretins.' In vitro radioperfusion and receptor-binding assays demonstrate that tirzepatide exhibits an affinity for the native GIP receptor comparable to endogenous GIP, while displaying approximately five-fold lower affinity for the GLP-1 receptor compared to native GLP-1.
- Accurate reconstitution of a 20mg [tirzepatide](/research-peptides/tirzepatide) vial requires precise micro-volumetric calculations to establish predictable stock concentrations.
Tirzepatide 20mg Overview: Content Specifications and Laboratory Application
A 20mg vial of tirzepatide contains a highly purified, lyophilized cake composed of twenty milligrams of active peptide mass paired with a stabilizing excipient matrix (such as mannitol or trehalose) to maintain structural integrity during vacuum-drying and storage. Tirzepatide itself is a synthetic 39-amino-acid peptide engineered with a C12-diacid acyl chain modification, designed to enable dual activation of both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. The 20mg mass concentration is specifically formulated for medium- to high-throughput research operations where multiple parallel assays or high-density microplate experiments require a uniform stock solution from a single batch preparation.
Principal investigators and laboratory managers typically order the 20mg format when conducting continuous preclinical studies that require persistent compound exposure without the analytical variance associated with reconstituting multiple smaller vials. By standardizing a experimental run around a single 20mg lot, researchers minimize intra-assay standard deviation across long-term cell culture experiments, binding affinity assays, or enzymatic degradation studies. For comprehensive access to various mass options, laboratories can browse our catalog of all peptides to align vial sizing with specific assay schedules.
PX1 Research Catalog Availability and Order Context
At PX1 Research, product offerings are constantly calibrated to match dynamic academic and industrial research demands. While custom batch runs and higher mass configurations are routinely processed for institutional partners, researchers seeking immediate dispatch should verify specific mass configurations against our current inventory. If a direct 20mg listing is currently cycling through production or reserved for contract accounts, laboratories are directed to explore equivalent mass totals through our available catalog formats, such as multi-vial options or specialized single-vial offerings like our GLP2-T peptide formulation.
Every vial dispatched from our California and Arizona fulfillment hubs—regardless of unit mass—is subject to identical manufacturing standards. We ensure ISO 17025 laboratory verification, high-performance liquid chromatography (HPLC) purity validation exceeding 98%, and comprehensive endotoxin testing. For custom bulk requirements or specialized vial fill requests, research institutions can set up dedicated ordering parameters through our wholesale lab account portal.
Molecular Mechanics: Dual GIP/GLP-1 Receptor Agonism
Tirzepatide represents a distinct structural class of incretin mimetics known as dual GIP/GLP-1 receptor agonists, or 'twincretins.' In vitro radioperfusion and receptor-binding assays demonstrate that tirzepatide exhibits an affinity for the native GIP receptor comparable to endogenous GIP, while displaying approximately five-fold lower affinity for the GLP-1 receptor compared to native GLP-1. This targeted balance triggers intracellular cyclic adenosine monophosphate (cAMP) accumulation through distinct signaling cascades, offering a unique biophysical model for metabolic pathways.
In cell-based reporter assays, this dual agonism drives downstream cellular cascades that modulate insulin secretion, gene expression, and lipid signaling pathways differently than selective single-receptor agonists. Preclinical rodent models investigating metabolic dynamics indicate that simultaneous activation of GIP and GLP-1 receptors yields synergistic effects on nutrient partitioning and central satiety signaling mechanisms. Researchers evaluating these pathways often design comparative studies alongside single-target compounds to delineate the specific contributions of dual receptor engagement.
Reconstitution Mathematics for a 20mg Lyophilized Vial
Accurate reconstitution of a 20mg tirzepatide vial requires precise micro-volumetric calculations to establish predictable stock concentrations. Depending on target pipetting volumes and assay sensitivity, laboratory staff typically employ 1.0 mL, 2.0 mL, or 3.0 mL of sterile diluent (such as bacteriostatic water containing 0.9% benzyl alcohol or sterile 0.9% sodium chloride). To calculate the working concentration ($C$), divide the total peptide mass ($M = 20\text{ mg}$) by the diluent volume ($V$): $C = M / V$.
When 1.0 mL of diluent is added to 20mg of lyophilized powder, the resulting concentration is exactly 20.0 mg/mL (or 20.0 \(\mu\)g/\(\mu\)L). Adding 2.0 mL of diluent yields a working concentration of 10.0 mg/mL (10.0 \(\mu\)g/\(\mu\)L). Reconstitution with 3.0 mL results in a concentration of approximately 6.67 mg/mL (6.67 \(\mu\)g/\(\mu\)L). For quick volumetric verification and custom concentration modeling, researchers should utilize our interactive reconstitution calculator before executing liquid handling protocols.
High-Volume Laboratory Aliquoting and Stability Planning
Once reconstituted, high-concentration peptide stock solutions are susceptible to chemical degradation via hydrolysis, oxidation, and non-specific adsorption to plastic container walls if left unmanaged. To preserve bioactivity across prolonged research timelines, working stock from a 20mg reconstitution should be immediately sub-aliquoted into single-use, low-binding polypropylene microcentrifuge tubes. Aliquoting eliminates repeated freeze-thaw cycles, which induce physical shear forces that disrupt primary peptide structures.
Aliquot size must be calculated according to daily assay throughput. For example, if an in vitro assay protocol requires 500 \(\mu\)g of tirzepatide per plate, a 10.0 mg/mL stock solution (from a 2.0 mL reconstitution) should be aliquoted into 50 \(\mu\)L volumes. Each tube is then sealed, labeled with lot identification and reconstitution date, and stored at -20°C or -80°C until immediate use. Thawed aliquots should be held at 2°C to 8°C and consumed within 24 to 48 hours to maintain assay integrity.
Vial Size Selection: Evaluating 20mg vs. Alternate Strengths
Selecting the optimal vial size depends heavily on the scale, frequency, and duration of the planned experimental design. The 20mg unit mass is uniquely advantageous for high-throughput screening environments, core facilities, or longitudinal animal studies where large working volumes are consumed within a short operational window. Utilizing a single 20mg vial reduces packaging waste, streamlines stock log tracking, and eliminates reconstituted batch-to-batch variation.
Conversely, for pilot studies, exploratory binding assays, or low-frequency benchwork, smaller mass options—such as 5mg or 10mg vials—may be superior. Smaller units prevent reconstituted material from sitting in liquid storage for extended periods, mitigating the risk of gradual peptide aggregation or loss of activity. Researchers can review structural data and mass configurations across our dedicated research guides, including our technical overview on tirzepatide 10mg, to establish the optimal procurement strategy.
Comparative Analysis: Incretin Peptide Class Properties
Within the broader landscape of incretin research, tirzepatide occupies a distinct functional classification due to its engineered dual-affinity profile. Comparative in vitro assays frequently benchmark tirzepatide against selective single-agonist compounds like semaglutide and liraglutide to contrast pure GLP-1 receptor activity against combined GIP/GLP-1 activation dynamics.
Additionally, emergent research evaluating multi-receptor agonists often compares tirzepatide's dual mechanism with triple-agonist compounds such as retatrutide, which targets GIP, GLP-1, and glucagon receptors simultaneously. Evaluated side-by-side in cell-based cAMP stimulation assays, these peptides demonstrate differing kinetics regarding receptor internalization, desensitization, and downstream transcriptional signaling. Understanding these subtle structural variations allows investigators to select the precise peptide candidate necessary for their specific physiological model.
Quality Assurance: HPLC Purity, Mass Spectrometry, and COAs
Assay reproducibility depends entirely on peptide purity and accurate mass verification. At PX1 Research, every production lot of tirzepatide undergoes rigorous analytical testing. Reversed-phase high-performance liquid chromatography (RP-HPLC) is performed to confirm a chemical purity profile exceeding 98%. Chromatographic integrity ensures the absence of truncated sequences, deletion peptides, or residual protecting groups stemming from solid-phase peptide synthesis (SPPS).
Mass identity is verified via Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) or electrospray ionization mass spectrometry (ESI-MS), matching observed molecular weight with theoretical sequence mass. Furthermore, every batch undergoes Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly under industry-established safety thresholds (< 0.05 EU/mg). Investigators can access lot-specific analytical documentation directly through our COA verification hub or explore expanded literature in our research library.
Laboratory Storage and Reconstituted Handling Protocols
Unopened, lyophilized tirzepatide 20mg vials should be stored in a dark, temperature-controlled environment at -20°C for long-term preservation (up to 24 months) or 2°C to 8°C for short-term storage (up to 90 days). The vacuum-sealed vial environment protects the desiccated peptide cake from atmospheric humidity and oxidative degradation. Vials should be allowed to equilibrate to room temperature before reconstitution to prevent moisture condensation inside the vial upon stopper puncture.
Reconstitution must be executed under sterile conditions using an aseptic laminar flow hood. Diluent should be introduced gently along the glass inner wall of the vial rather than sprayed directly onto the lyophilized cake. Gentle swirly agitation should be applied until complete dissolution occurs; vigorous shaking or vortexing must be avoided as mechanical agitation can induce protein denaturation and visible precipitation. Once dissolved, the clear solution must be inspected visually for particulate matter prior to experimental use.
Frequently Asked Questions
What is the exact mass contained in a tirzepatide 20mg vial?
A tirzepatide 20mg vial contains 20 milligrams of active, high-purity tirzepatide peptide supplied as a sterile, lyophilized (freeze-dried) powder, alongside inert stabilizing excipients.
How is a 20mg tirzepatide vial reconstituted for laboratory use?
A precise volume of sterile diluent (such as bacteriostatic water) is injected against the inner glass wall of the vial. Adding 1.0 mL yields a 20.0 mg/mL solution, 2.0 mL yields a 10.0 mg/mL solution, and 3.0 mL yields a 6.67 mg/mL solution.
Where can I find the lot-matched Certificate of Analysis (COA) for my vial?
Lot-specific COAs detailing HPLC purity, mass spectrometry identification, and endotoxin assay results can be searched and downloaded directly from the PX1 Research COA portal using the lot number printed on the vial label.
How should reconstituted tirzepatide be stored in the lab?
Reconstituted stock solutions should be sub-aliquoted into single-use microcentrifuge tubes and stored at -20°C or -80°C to avoid repeated freeze-thaw cycles. Active working aliquots held at 2°C to 8°C should be used within 24 to 48 hours.
What endotoxin limits apply to PX1 Research peptides?
PX1 Research enforces strict quality standards, ensuring all research peptides undergo LAL endotoxin testing to guarantee levels remain below 0.05 EU/mg, minimizing non-specific cellular reactions in sensitive assays.
What are the primary receptor targets of tirzepatide?
Tirzepatide is a dual agonist engineered to bind and activate both the GIP (glucose-dependent insulinotropic polypeptide) receptor and the GLP-1 (glucagon-like peptide-1) receptor in preclinical model systems.
When is a 20mg vial preferable over a 5mg or 10mg vial?
A 20mg vial is ideal for high-throughput screening, multi-plate in vitro assays, or multi-animal longitudinal studies where high compound volume is required quickly from a single standardized lot.
Does PX1 Research offer same-day shipping on research compounds?
Yes, PX1 Research dispatches orders same-day Monday through Friday for orders placed before daily cutoff times, shipping directly from specialized fulfillment centers in California and Arizona.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.